These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6386646)

  • 1. Effect of pharmacological doses of oxytocin on insulin response to glucose in normal man.
    Chiodera P; Coiro V; Camellini L; Rossi G; Pignatti D; Volpi R; Roti E
    Horm Res; 1984; 20(2):150-4. PubMed ID: 6386646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological doses of oxytocin affect plasma hormone levels modulating glucose homeostasis in normal man.
    Paolisso G; Sgambato S; Passariello N; Torella R; Giugliano D; Mignano S; Varricchio M; D'Onofrio F
    Horm Res; 1988; 30(1):10-6. PubMed ID: 3065208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oxytocin delivery on counter-regulatory hormone response in insulin-dependent (type 1) diabetic subjects.
    Paolisso G; Sgambato S; Giugliano D; Pizza G; Tesauro P; Varricchio M; D'Onofrio F
    Horm Res; 1989; 31(5-6):250-5. PubMed ID: 2693310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Actions of intravenous injections of AVP and oxytocin on plasma ACTH, GH, insulin and glucagon concentrations in goats.
    Roh SG; Koiwa K; Sato K; Ohtani Y; Takahashi T; Katoh K
    Anim Sci J; 2014 Mar; 85(3):286-92. PubMed ID: 24206398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxytocin Improves β-Cell Responsivity and Glucose Tolerance in Healthy Men.
    Klement J; Ott V; Rapp K; Brede S; Piccinini F; Cobelli C; Lehnert H; Hallschmid M
    Diabetes; 2017 Feb; 66(2):264-271. PubMed ID: 27554476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of a peripheral and a central effect of oxytocin on pancreatic hormone release in rats.
    Björkstrand E; Eriksson M; Uvnäs-Moberg K
    Neuroendocrinology; 1996 Apr; 63(4):377-83. PubMed ID: 8739893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
    Saccà L; Sherwin R; Hendler R; Felig P
    J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of the effect of oxytocin on plasma concentrations of glucose, insulin and glucagon in conscious dogs.
    Vilhardt H; Krarup T; Holst JJ; Bie P
    J Endocrinol; 1986 Feb; 108(2):293-8. PubMed ID: 2869096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of counterregulatory hormone secretion in man during exercise and hypoglycemia.
    Sotsky MJ; Shilo S; Shamoon H
    J Clin Endocrinol Metab; 1989 Jan; 68(1):9-16. PubMed ID: 2642489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of naloxone on beta-endorphin and insulin concentrations during glucose tolerance testing in patients with simple obesity].
    Krzyzanowska-Swiniarska B; Gruszczyńska M; Pilarska K; Widecka K; Czekalski S
    Endokrynol Pol; 1993; 44(4):517-29. PubMed ID: 8055820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of oxytocin on the plasma glucagon response to insulin-induced hypoglycaemia in man.
    Page SR; Ang VT; Jackson R; Nussey SS
    Diabete Metab; 1990; 16(3):248-51. PubMed ID: 2210021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of metformin on plasma glucose, insulin, FFA, glucagon, growth hormone and cortisol responses to oral glucose in subjects with chemical diabetes.
    Giugliano D; Torella R; Improta L; Scognamiglio G
    Farmaco Prat; 1979 Jan; 34(1):32-41. PubMed ID: 378687
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of oxytocin, arginine-vasopressin and lysine-vasopressin on insulin and glucagon secretion in sheep.
    Mineo H; Ito M; Muto H; Kamita H; Hyun HS; Onaga T; Yanaihara N
    Res Vet Sci; 1997; 62(2):105-10. PubMed ID: 9243706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscarinic cholinergic modulation of insulin response to an intravenous glucose tolerance test in normal man.
    Coiro V; Chiodera P; Volpi R; d'Amato L; Camellini L; Rossi G; Pignatti D; Butturini U
    J Endocrinol Invest; 1986 Feb; 9(1):27-30. PubMed ID: 3517121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prandial regulation of ghrelin secretion in humans: does glucagon contribute to the preprandial increase in circulating ghrelin?
    Soule S; Pemberton C; Hunt P; Cole D; Raudsepp S; Inder W
    Clin Endocrinol (Oxf); 2005 Oct; 63(4):412-7. PubMed ID: 16181233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol, glucagon and growth hormone responses to oral glucose in non-insulin-dependent diabetes in the young.
    Jialal I; Joubert SM
    S Afr Med J; 1982 Oct; 62(16):549-52. PubMed ID: 6750813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACTH and cortisol responses to glucagon stimulation.
    Waldhäusl W; Haydl H; Nowotny P
    J Clin Endocrinol Metab; 1976 Sep; 43(3):675-8. PubMed ID: 182712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-vasopressin inhibits oxytocin-induced increases of plasma levels of insulin conscious dogs.
    Stock S; Uvnäs-Moberg K
    Acta Physiol Scand; 1987 May; 130(1):55-61. PubMed ID: 3296661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in the glucagon and growth hormone levels in the blood plasma of healthy persons and of patients with disordered glucose tolerance after insulin administration].
    Tikhonova NE; Alekseeva GG
    Probl Endokrinol (Mosk); 1986; 32(1):22-5. PubMed ID: 3513155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence against important catecholamine compensation for absent glucagon counterregulation.
    De Feo P; Perriello G; Torlone E; Fanelli C; Ventura MM; Santeusanio F; Brunetti P; Gerich JE; Bolli GB
    Am J Physiol; 1991 Feb; 260(2 Pt 1):E203-12. PubMed ID: 1996624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.